688575 亚辉龙
已收盘 10-08 15:00:00
资讯
新帖
简况
股市必读：10月8日亚辉龙现2笔折价19.79%的大宗交易 合计成交514.61万元
证券之星 · 03:02
股市必读：10月8日亚辉龙现2笔折价19.79%的大宗交易 合计成交514.61万元
股市必读：亚辉龙新发布《公司章程（2026年9月)》
证券之星 · 10-08 02:48
股市必读：亚辉龙新发布《公司章程（2026年9月)》
亚辉龙（688575）披露关于变更注册资本暨修订《公司章程》的公告，9月30日股价上涨2.23%
证券之星 · 09-30
亚辉龙（688575）披露关于变更注册资本暨修订《公司章程》的公告，9月30日股价上涨2.23%
亚辉龙（688575）披露2023年限制性股票激励计划第二个归属期（第二批）归属结果暨股票上市公告，9月22日股价上涨1.95%
证券之星 · 09-22
亚辉龙（688575）披露2023年限制性股票激励计划第二个归属期（第二批）归属结果暨股票上市公告，9月22日股价上涨1.95%
亚辉龙：9月16日董事胡鹍辉增持股份合计3万股
证券之星 · 09-17
亚辉龙：9月16日董事胡鹍辉增持股份合计3万股
每周股票复盘：亚辉龙（688575）董事胡鹍辉增持26.0万股
证券之星 · 09-13
每周股票复盘：亚辉龙（688575）董事胡鹍辉增持26.0万股
亚辉龙：9月8日董事胡鹍辉增持股份合计26万股
证券之星 · 09-08
亚辉龙：9月8日董事胡鹍辉增持股份合计26万股
亚辉龙（688575）披露2026年限制性股票激励计划首次授予激励对象名单公示情况及核查意见，9月8日股价上涨1.29%
证券之星 · 09-08
亚辉龙（688575）披露2026年限制性股票激励计划首次授予激励对象名单公示情况及核查意见，9月8日股价上涨1.29%
每周股票复盘：亚辉龙（688575）Q2净利增223.67%
证券之星 · 08-30
每周股票复盘：亚辉龙（688575）Q2净利增223.67%
亚辉龙（688575）2026年中报简析：营收净利润同比双双增长，公司应收账款体量较大
证券之星 · 08-28
亚辉龙（688575）2026年中报简析：营收净利润同比双双增长，公司应收账款体量较大
亚辉龙最新公告：2026年半年度净利润同比增长166.97%
证券之星 · 08-26
亚辉龙最新公告：2026年半年度净利润同比增长166.97%
每周股票复盘：亚辉龙（688575）获两款器械注册证
证券之星 · 08-23
每周股票复盘：亚辉龙（688575）获两款器械注册证
亚辉龙获得发明专利授权：“分子检测装置以及检测方法”
证券之星 · 08-08
亚辉龙获得发明专利授权：“分子检测装置以及检测方法”
每周股票复盘：亚辉龙（688575）获6项医疗器械注册证
证券之星 · 08-02
每周股票复盘：亚辉龙（688575）获6项医疗器械注册证
股市必读：亚辉龙（688575）新发布《关于自愿披露取得医疗器械注册证的公告》
证券之星 · 07-31
股市必读：亚辉龙（688575）新发布《关于自愿披露取得医疗器械注册证的公告》
亚辉龙最新公告：取得6项微流控化学发光法检测试剂医疗器械注册证
证券之星 · 07-29
亚辉龙最新公告：取得6项微流控化学发光法检测试剂医疗器械注册证
亚辉龙（688575）披露为全资子公司提供担保公告，7月24日股价下跌5.44%
证券之星 · 07-24
亚辉龙（688575）披露为全资子公司提供担保公告，7月24日股价下跌5.44%
亚辉龙：7月21日董事胡鹍辉增持股份合计10万股
证券之星 · 07-22
亚辉龙：7月21日董事胡鹍辉增持股份合计10万股
亚辉龙：7月20日董事胡鹍辉增持股份合计6万股
证券之星 · 07-21
亚辉龙：7月20日董事胡鹍辉增持股份合计6万股
亚辉龙获得实用新型专利授权：“处理装置”
证券之星 · 07-07
亚辉龙获得实用新型专利授权：“处理装置”
加载更多
公司概况
公司名称：
深圳市亚辉龙生物科技股份有限公司
所属行业：
医药制造业
上市日期：
2021-05-17
主营业务：
深圳市亚辉龙生物科技股份有限公司的主营业务是体外诊断仪器及配套试剂、耗材的研发、生产、销售和服务。公司的主要产品是体外诊断仪器、配套试剂。
发行价格：
14.80
{"stockData":{"symbol":"688575","market":"SH","secType":"STK","nameCN":"亚辉龙","latestPrice":10.51,"timestamp":1791442800000,"preClose":10.53,"halted":0,"volume":10783794,"delay":0,"changeRate":-0.0019,"floatShares":571000000,"shares":571000000,"eps":0.1177,"marketStatus":"已收盘","change":-0.02,"latestTime":"10-08 15:00:00","open":10.64,"high":10.77,"low":10.34,"amount":113000000,"amplitude":0.0408,"askPrice":10.51,"askSize":28,"bidPrice":10.5,"bidSize":101,"shortable":0,"etf":0,"ttmEps":0.1177,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791509400000},"marketStatusCode":5,"adr":0,"adjPreClose":10.53,"symbolType":"stock_kcb","openAndCloseTimeList":[[1791423000000,1791430200000],[1791435600000,1791442800000]],"highLimit":11.58,"lowLimit":9.48,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":571418300,"isCdr":false,"pbRate":2.18,"roa":"--","peRate":89.294817,"roe":"2.57%","epsLYR":0.04,"committee":-0.487535,"marketValue":6006000000,"turnoverRate":0.0189,"status":1,"afterMarket":{"amount":0,"volume":0,"close":10.51,"buyVolume":5500,"sellVolume":0,"time":1791444837746,"indexStatus":"已收盘 10-08 15:30:00","preClose":10.53},"floatMarketCap":6006000000},"requestUrl":"/m/hq/s/688575","defaultTab":"news","newsList":[{"id":"2674600249","title":"股市必读：10月8日亚辉龙现2笔折价19.79%的大宗交易 合计成交514.61万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2674600249","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674600249?lang=zh_cn&edition=full","pubTime":"2026-10-09 03:02","pubTimestamp":1791486133,"startTime":"0","endTime":"0","summary":"截至2026年10月8日收盘，亚辉龙报收于10.51元，下跌0.19%，换手率1.89%，成交量10.78万手，成交额1.13亿元。当日关注点交易信息汇总：10月8日亚辉龙主力资金净流出172.25万元，占总成交额1.52%； 交易信息汇总：当日发生2笔折价19.79%的大宗交易，合计成交514.61万元。大宗交易10月8日亚辉龙发生2笔折价19.79%的大宗交易，合计成交514.61万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900002667.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688575"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673017330","title":"股市必读：亚辉龙新发布《公司章程（2026年9月)》","url":"https://stock-news.laohu8.com/highlight/detail?id=2673017330","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673017330?lang=zh_cn&edition=full","pubTime":"2026-10-08 02:48","pubTimestamp":1791398892,"startTime":"0","endTime":"0","summary":"薪酬与考核委员会关于公司2026年限制性股票激励计划首次授予激励对象名单的核查意见薪酬与考核委员会核查确认：激励对象不存在被监管机构认定为不适当人选等禁止情形，未包括独立董事、持股5%以上股东及实际控制人及其关联人，人员名单与股东大会批准的计划相符；激励对象具备相关法律法规及公司章程规定的任职资格和激励条件；同意以4.74元/股向96名激励对象首次授予348.50万股限制性股票，授予日为2026年9月30日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800001398.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688575","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671788411","title":"亚辉龙（688575）披露关于变更注册资本暨修订《公司章程》的公告，9月30日股价上涨2.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2671788411","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671788411?lang=zh_cn&edition=full","pubTime":"2026-09-30 22:25","pubTimestamp":1790778318,"startTime":"0","endTime":"0","summary":"截至2026年9月30日收盘，亚辉龙报收于10.53元，较前一交易日上涨2.23%，最新总市值为60.17亿元。近日，深圳市亚辉龙生物科技股份有限公司发布《关于变更注册资本暨修订〈公司章程〉的公告》。公司据此修订《公司章程》相关条款，修订内容涉及注册资本和股份总数，授权管理层办理工商变更手续。本次变更无需提交股东大会审议，修订后的《公司章程》将披露于上交所网站。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000038110.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688575","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669148768","title":"亚辉龙（688575）披露2023年限制性股票激励计划第二个归属期（第二批）归属结果暨股票上市公告，9月22日股价上涨1.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669148768","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669148768?lang=zh_cn&edition=full","pubTime":"2026-09-22 17:46","pubTimestamp":1790070385,"startTime":"0","endTime":"0","summary":"近日，深圳市亚辉龙生物科技股份有限公司发布《关于2023年限制性股票激励计划第二个归属期（第二批）归属结果暨股票上市公告》。公告显示，公司已完成2023年限制性股票激励计划第二个归属期（第二批）的股份登记工作，本次归属股票数量为30,000股，涉及1名激励对象，为副总经理兼核心技术人员肖育劲，归属价格为9.10元/股，新增股份已于2026年9月18日完成登记，上市流通日期为2026年9月28日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092200031298.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688575"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668964429","title":"亚辉龙：9月16日董事胡鹍辉增持股份合计3万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2668964429","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668964429?lang=zh_cn&edition=full","pubTime":"2026-09-17 20:02","pubTimestamp":1789646522,"startTime":"0","endTime":"0","summary":"证券之星消息，根据9月17日市场公开信息、上市公司公告及交易所披露数据整理，亚辉龙最新董监高及相关人员股份变动情况：2026年9月16日公司董事胡鹍辉共增持公司股份3.0万股，占公司总股本为0.0053%。变动期间公司股价上涨0.85%，9月16日当日收盘报9.45元。亚辉龙近半年内的董监高及核心技术人员增减持详情如下：亚辉龙的高管列表及最新持股情况如下：融资融券数据显示该股近5日融资净流入443.81万，融资余额增加；融券净流入93.0，融券余额增加。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091700032931.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688575","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667500692","title":"每周股票复盘：亚辉龙（688575）董事胡鹍辉增持26.0万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2667500692","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667500692?lang=zh_cn&edition=full","pubTime":"2026-09-13 03:25","pubTimestamp":1789241111,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，亚辉龙报收于9.53元，较上周的10.11元下跌5.74%。本周，亚辉龙9月9日盘中最高价报10.27元。本周关注点股本股东变化：董事胡鹍辉增持26.0万股，占总股本0.0455%。公司公告汇总薪酬与考核委员会就公司2026年限制性股票激励计划首次授予激励对象名单的公示情况出具说明及核查意见。2026年8月27日至9月6日，公司在内部公示了首次授予激励对象的姓名和职务，公示期不少于10天，期间未收到任何异议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091300001050.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688575"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665320610","title":"亚辉龙：9月8日董事胡鹍辉增持股份合计26万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2665320610","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665320610?lang=zh_cn&edition=full","pubTime":"2026-09-08 20:01","pubTimestamp":1788868893,"startTime":"0","endTime":"0","summary":"证券之星消息，根据9月8日市场公开信息、上市公司公告及交易所披露数据整理，亚辉龙最新董监高及相关人员股份变动情况：2026年9月8日公司董事胡鹍辉共增持公司股份26.0万股，占公司总股本为0.0455%。亚辉龙近半年内的董监高及核心技术人员增减持详情如下：亚辉龙的高管列表及最新持股情况如下：融资融券数据显示该股近5日融资净流出2801.21万，融资余额减少；融券净流入3.75万，融券余额增加。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800033241.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688575"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665321656","title":"亚辉龙（688575）披露2026年限制性股票激励计划首次授予激励对象名单公示情况及核查意见，9月8日股价上涨1.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665321656","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665321656?lang=zh_cn&edition=full","pubTime":"2026-09-08 18:00","pubTimestamp":1788861618,"startTime":"0","endTime":"0","summary":"截至2026年9月8日收盘，亚辉龙报收于10.23元，较前一交易日上涨1.29%，最新总市值为58.45亿元。亚辉龙于2026年9月8日披露《薪酬与考核委员会关于公司2026年限制性股票激励计划首次授予激励对象名单的公示情况说明及核查意见》公告。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800028585.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688575"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663153010","title":"每周股票复盘：亚辉龙（688575）Q2净利增223.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663153010","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663153010?lang=zh_cn&edition=full","pubTime":"2026-08-30 03:05","pubTimestamp":1788030313,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，亚辉龙报收于10.39元，较上周的9.55元上涨8.8%。股本股东变化股东户数变动截至2026年6月30日，公司股东户数为1.4万户，较3月31日增加2388.0户，增幅20.48%。第二季度单季主营收入4.9亿元，同比上升25.47%；单季度归母净利润5218.02万元，同比上升223.67%；单季度扣非净利润4873.33万元，同比上升271.19%。2026年度“提质增效重回报”行动方案的半年度评估报告2026年上半年，公司实现营业收入88,795.96万元，同比增长9.84%；归母净利润7,013.08万元，同比增长166.97%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000001021.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688575"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662039348","title":"亚辉龙（688575）2026年中报简析：营收净利润同比双双增长，公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2662039348","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662039348?lang=zh_cn&edition=full","pubTime":"2026-08-28 06:20","pubTimestamp":1787869224,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期亚辉龙发布2026年中报。截至本报告期末，公司营业总收入8.88亿元，同比上升9.84%，归母净利润7013.08万元，同比上升166.97%。本报告期亚辉龙公司应收账款体量较大，当期应收账款占最新年报归母净利润比达2599.77%。本次财报公布的各项数据指标表现尚佳。去年的净利率为3.77%，算上全部成本后，公司产品或服务的附加值不高。本文数据来源于亚辉龙2026年中报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800011040.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688575"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662117714","title":"亚辉龙最新公告：2026年半年度净利润同比增长166.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662117714","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662117714?lang=zh_cn&edition=full","pubTime":"2026-08-26 21:01","pubTimestamp":1787749268,"startTime":"0","endTime":"0","summary":"亚辉龙(688575.SH)公告称，公司发布2026年半年度报告，实现营业收入8.88亿元，同比增长9.84%；归属于上市公司股东的净利润7013.08万元，同比增长166.97%。注：公司Q2净利润0.52亿，Q1净利润0.18亿，据此计算，Q2净利润环比增长190%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600048948.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688575"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661117572","title":"每周股票复盘：亚辉龙（688575）获两款器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2661117572","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661117572?lang=zh_cn&edition=full","pubTime":"2026-08-23 02:40","pubTimestamp":1787424019,"startTime":"0","endTime":"0","summary":"截至2026年8月21日收盘，亚辉龙报收于9.55元，较上周的10.12元下跌5.63%。本周，亚辉龙8月17日盘中最高价报10.23元。亚辉龙当前最新总市值54.57亿元，在医疗器械板块市值排名67/129，在两市A股市值排名2927/5210。本次获证为公司承担‘十四五’国家重点研发计划项目的研究任务之一，有助于提升公司核心竞争力。上述产品已具备国内上市资格，但未来销售受市场环境等因素影响，存在不确定性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082300000502.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688575","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657625912","title":"亚辉龙获得发明专利授权：“分子检测装置以及检测方法”","url":"https://stock-news.laohu8.com/highlight/detail?id=2657625912","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657625912?lang=zh_cn&edition=full","pubTime":"2026-08-08 03:38","pubTimestamp":1786131527,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示亚辉龙新获得一项发明专利授权，专利名为“分子检测装置以及检测方法”，专利申请号为CN202511849673.9，授权日为2026年8月7日。本申请实施例的一种分子检测装置以及检测方法，具有结构简单且检测精度高优点。今年以来亚辉龙新获得专利授权25个，较去年同期减少了19.35%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080800003656.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688575"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656316728","title":"每周股票复盘：亚辉龙（688575）获6项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2656316728","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656316728?lang=zh_cn&edition=full","pubTime":"2026-08-02 02:35","pubTimestamp":1785609311,"startTime":"0","endTime":"0","summary":"截至2026年7月31日收盘，亚辉龙报收于9.17元，较上周的8.52元上涨7.63%。本周，亚辉龙7月30日盘中最高价报9.3元。亚辉龙当前最新总市值52.4亿元，在医疗器械板块市值排名64/129，在两市A股市值排名2878/5202。本周关注点公司公告汇总：亚辉龙取得6项微流控化学发光法检测试剂医疗器械注册证。本次获证有助于提升公司核心竞争力，但项目推进及产品销售存在不确定性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080200000710.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09996","BK1583","BK0239","BK1574","688575","BK1100","159883"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655380722","title":"股市必读：亚辉龙（688575）新发布《关于自愿披露取得医疗器械注册证的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2655380722","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655380722?lang=zh_cn&edition=full","pubTime":"2026-07-31 02:01","pubTimestamp":1785434480,"startTime":"0","endTime":"0","summary":"截至2026年7月30日收盘，亚辉龙报收于9.06元，上涨0.55%，换手率1.26%，成交量7.19万手，成交额6565.99万元。公司公告汇总：亚辉龙近日取得6项微流控化学发光法检测试剂医疗器械注册证，涉及高敏肌钙蛋白I等6个检测项目，均为二类医疗器械，有效期至2031年7月。上述产品系公司承担“十四五”国家重点研发计划“高性能免疫现场快速检测系统研发”项目的研究任务之一，用于心肌梗死、心力衰竭等疾病的辅助诊断。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073100001489.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","BK0239","09996","688575","159883","BK1574","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655694948","title":"亚辉龙最新公告：取得6项微流控化学发光法检测试剂医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2655694948","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655694948?lang=zh_cn&edition=full","pubTime":"2026-07-29 18:30","pubTimestamp":1785321032,"startTime":"0","endTime":"0","summary":"亚辉龙(688575.SH)公告称，公司收到广东省药品监督管理局签发的6项微流控化学发光法检测试剂医疗器械注册证，包括高敏肌钙蛋白I测定试剂盒、N末端B型利钠肽前体测定试剂盒等，主要用于心肌梗死、心力衰竭等疾病的辅助诊断。本次获证是公司承担“十四五”国家重点研发计划项目的阶段性成果，有助于提升核心竞争力。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072900032856.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688575","159883","09996","BK1574","BK0239","BK1100","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653038700","title":"亚辉龙（688575）披露为全资子公司提供担保公告，7月24日股价下跌5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653038700","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653038700?lang=zh_cn&edition=full","pubTime":"2026-07-24 22:24","pubTimestamp":1784903040,"startTime":"0","endTime":"0","summary":"截至2026年7月24日收盘，亚辉龙报收于8.52元，较前一交易日下跌5.44%，最新总市值为48.68亿元。近日，深圳市亚辉龙生物科技股份有限公司披露《关于为全资子公司提供担保的公告》。公司为全资子公司开源医疗、科路仕、锐普佳和湖南亚辉龙向招商银行深圳分行申请授信提供连带责任保证担保，担保最高本金余额合计11,500万元。截至公告日，公司对上述子公司已实际提供担保余额20,373.41万元，对外担保余额29,063.42万元，无逾期担保。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072400042179.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688575","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653757715","title":"亚辉龙：7月21日董事胡鹍辉增持股份合计10万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2653757715","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653757715?lang=zh_cn&edition=full","pubTime":"2026-07-22 20:02","pubTimestamp":1784721723,"startTime":"0","endTime":"0","summary":"证券之星消息，根据7月22日市场公开信息、上市公司公告及交易所披露数据整理，亚辉龙最新董监高及相关人员股份变动情况：2026年7月21日公司董事胡鹍辉共增持公司股份10.0万股，占公司总股本为0.0175%。变动期间公司股价下跌1.72%，7月21日当日收盘报9.13元。亚辉龙近半年内的董监高及核心技术人员增减持详情如下：亚辉龙的高管列表及最新持股情况如下：融资融券数据显示该股近5日融资净流入550.97万，融资余额增加；融券净流出900.0，融券余额减少。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072200043382.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688575"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653272269","title":"亚辉龙：7月20日董事胡鹍辉增持股份合计6万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2653272269","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653272269?lang=zh_cn&edition=full","pubTime":"2026-07-21 20:01","pubTimestamp":1784635315,"startTime":"0","endTime":"0","summary":"证券之星消息，根据7月21日市场公开信息、上市公司公告及交易所披露数据整理，亚辉龙最新董监高及相关人员股份变动情况：2026年7月20日公司董事胡鹍辉共增持公司股份6.0万股，占公司总股本为0.0105%。变动期间公司股价下跌0.75%，7月20日当日收盘报9.29元。亚辉龙近半年内的董监高及核心技术人员增减持详情如下：亚辉龙的高管列表及最新持股情况如下：融资融券数据显示该股近5日融资净流入696.16万，融资余额增加；融券净流入1000.0，融券余额增加。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072100040185.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688575","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649798336","title":"亚辉龙获得实用新型专利授权：“处理装置”","url":"https://stock-news.laohu8.com/highlight/detail?id=2649798336","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649798336?lang=zh_cn&edition=full","pubTime":"2026-07-07 03:24","pubTimestamp":1783365896,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示亚辉龙新获得一项实用新型专利授权，专利名为“处理装置”，专利申请号为CN202521453701.0，授权日为2026年7月7日。如此可以提高处理装置对各种工况的适用性。今年以来亚辉龙新获得专利授权22个，较去年同期减少了18.52%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070700003584.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688575","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1791500907251,"stockEarnings":[{"period":"1week","weight":-0.0019},{"period":"1month","weight":0.0274},{"period":"3month","weight":0.1537},{"period":"6month","weight":-0.2907},{"period":"1year","weight":-0.2761},{"period":"ytd","weight":-0.2582}],"compareEarnings":[{"period":"1week","weight":-0.0079},{"period":"1month","weight":-0.0326},{"period":"3month","weight":-0.0461},{"period":"6month","weight":-0.0437},{"period":"1year","weight":-0.0183},{"period":"ytd","weight":-0.0395}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"深圳市亚辉龙生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"14048人(较上一季度增加20.48%)","perCapita":"40676股","listingDate":"2021-05-17","address":"广东省深圳市龙岗区宝龙街道宝龙二路亚辉龙生物科技厂区1栋","registeredCapital":"57141万元","survey":" 深圳市亚辉龙生物科技股份有限公司的主营业务是体外诊断仪器及配套试剂、耗材的研发、生产、销售和服务。公司的主要产品是体外诊断仪器、配套试剂。","listedPrice":14.8},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"亚辉龙(688575)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供亚辉龙(688575)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"亚辉龙,688575,亚辉龙股票,亚辉龙股票老虎,亚辉龙股票老虎国际,亚辉龙行情,亚辉龙股票行情,亚辉龙股价,亚辉龙股市,亚辉龙股票价格,亚辉龙股票交易,亚辉龙股票购买,亚辉龙股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"亚辉龙(688575)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供亚辉龙(688575)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}